of shares held is also included in Note 11)-- but I expect potential
YTD cash generation & investment gains more than compensates...
(EUR 14.0 M Revenue * 1.2 P / S + 3.2 M Debt Adjustment + 2.7 M Cash + 0.4 M Option Cash + 0.6 M
YTD Cash Generation) / (97.9 M Shares + 7.8 M Option Shares) = EUR 0.225 Fair Value per share
--
YTD cash generation: We're already well into May — taking last year's 2.3 M of FCF, we might expect another 0.9 M of cash generated YTD.
Not exact matches
At a high - level, I see QCOM as a conservatively capitalized (Debt / Equity = 36 %), free
cash flow generating (FCF = ~ $ 5B 12 - months
YTD), financially stable company (A + / Stable, A1 / Stable), who recently grew their dividend by over 10 %.
YTD, CVX has generated negative free
cash flow of about $ 5 billion (closer to flat including asset sales), and COP's free
cash flow checks in at negative $ 2.1 billion (including asset sales).
From a cost perspective, XOM has reduced capital and
cash operating costs by $ 8 billion
YTD (3.8 % of sales) and should make additional progress in future quarters.
Distribution (
YTD) does not include special
cash dividends.
I'm no pension accounting expert, so feel free to elighten me, but wouldn't the
cash effects of any funding
YTD, be reflected in the 9/30 (9 months ending) free
cash flow which I have at 1.55 per share, diluted.
$ 12.9 Billion
Cash + $ 73.4 B Mktble Securities + $ 5.9 B Inv» ts + $ 1.4 B Pro Note + $ 0.8 B Temasek Deal + $ 5.3 B FCF
YTD = $ 99.7 B Total
Cash & Investments = $ 145
Cash & Investments per Share
In the chart below, we look at the
YTD performance of
cash - heavy funds through early May.